ACA vs MTHRY
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ACA · Arcosa$149.15 ▲ 0.00%
MTHRY · M3 (ADR)$5.69 ▼ 3.40%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ACA +49.3%
- MTHRY -10.3%
Head to head
| Metric | ACA | MTHRY |
|---|---|---|
| Price | $149.15 | $5.69 |
| Change today | ▲ 0.00% | ▼ 3.40% |
| Market cap | $7.32B | $7.33B |
| Return, 3 months | +2.9% | +12.7% |
| Return, year to date | +40.5% | -14.6% |
| Return, 1 year | +60.5% | -16.7% |
| P/E (TTM) | 15.0 | 25.9 |
| P/B | 2.5 | 2.9 |
| P/E percentile vs own 5y | 24th | – |
| Dividend yield | 0.13% | 1.21% |
| Revenue growth (YoY, latest qtr) | +1.7% | – |
| Net profit growth (YoY) | +450.3% | – |
| Gross margin | 22.8% | – |
| Operating margin | 12.0% | – |
| Net margin | 16.8% | – |
| Return on equity | 17.9% | – |
| Analyst target vs. price | +0.6% | – |
| Analyst buy share | 0% | – |
| RSI (14) | 83 | 48 |
| 30-day volatility | 3.9% | 49.6% |
| Max drawdown, 1 year | -21.4% | -53.5% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Hold | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MTHRY is the largest of the group by market value.
- ACA has returned the most over the past year.
- ACA carries the lowest trailing P/E.
- MTHRY pays the highest dividend yield.
- ACA has been the calmest stock over the last 30 days.